Keywords: 5â²AMP; 5â² adenosine monophosphate; ADO; adenosine; DSAs; anti-donor specific antibodies; APC; antigen-presenting cell; CXCL-9; chemokine (C-X-C motif) ligand 9; cAMP; cyclic adenosine monophosphate; CTLA4; cytotoxic T-lymphocyte associated protein 4;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Allergic rhinitis; TLR7/8; Resiquimod; IL-25; IL-33; TIM3;
Keywords: ARID; Age Related Immune Differences; CD40L; CD40 ligand; CTLA-4; cytotoxic T lymphocyte antigen-4; IL; interleukin; Lag3; lymphocyte activation gene 3; MDSC; myeloid derived suppressor cell; MHC; major histocompatibility complex; mTOR; mammalian target o
Keywords: ARID; Age Related Immune Dysfunction; BCG; Bacille Calmette-Guérin; CAR; chimeric antigen receptor; CDMRP; Congressionally Directed Medical Research Program; CD40L; CD40 ligand; CpG; poly-(cysteine 5â² to guanine); CRISPR; clustered regularly interspace
Keywords: Ag; antigen; APC; antigen presenting cell; AQP4; aquaporin 4; BDNF; brain-derived neurotrophic factor; CD; cluster of differentiation; CCL; C-C ligand; chABC; chondroitinase ABC; CNS; central nervous system; COX; cyclooxygenase; CTLA-4; cytotoxic T lymp
Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma
Keywords: TIM3; Protéine PD-1; TILs; HBV; Carcinome hépatocellulaire; TIM3 (T cell Ig- and mucin-domain-containing molecule-3); PD-1 (Programmed cell death 1); TILs; HBV: hepatocellular carcinoma;
Tim3/galectin-9 alleviates the inflammation of TAO patients via suppressing Akt/NF-kB signaling pathway
Keywords: Tim3; Galectin-9; Inflammation; Thyroid-associated ophthalmopathy; Akt/NF-κB;
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
Keywords: Immunotherapy; GPC3; MAGEC2; Galectin 9; APC; antigen-presenting cells; BTLA; BÂ and T lymphocyte attenuator; CFSE; carboxyfluorescein diacetate succinimidyl ester; CTL; cytotoxic T cells; CTLA4; cytotoxic T-lymphocyte associated protein 4; GAL-9; galecti
Clinical StudyClinical significance of Tim3-positive T cell subsets in patients with multiple sclerosis
Keywords: Tim3; Flow cytometry; CD4+CD25(high) T cell; Galectin-9;
Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer
Keywords: Pancreatic cancer; T cells; Exhaustion; Immunotherapy; ACT; adoptive cell transfer; AP-1; activator protein-1; APC; antigen-presenting cells; CAR; chimeric antigen receptor; CTL; cytotoxic T cells; CTLA-4; cytotoxic T lymphocyte antigen 4; FDA; US Food an
Elevated TIM3+ hematopoietic stem cells in untreated myelodysplastic syndrome displayed aberrant differentiation, overproliferation and decreased apoptosis
Keywords: TIM3; Myelodysplastic syndrome; Hematopoietic stem cells; Differentiation; Proliferation; Apoptosis;
Loss of CD28 Expression by Liver-Infiltrating T Cells Contributes to Pathogenesis of Primary Sclerosing Cholangitis
Keywords: Interferon; Autoimmunity; Biliary Epithelial Cells; Immune Regulation; BEC; biliary epithelial cell; CCR; C-C chemokine receptor; CXCR; C-X3-C motif receptor; DC; disease control; ICAM1; intercellular cell adhesion molecule-1; IFNγ; interferon γ; IL; in
Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection
Keywords: Chronic hepatitis B virus infection; Cirrhosis; Hepatocellular carcinoma; PD1; TIM3; Polymorphism;
Transfer of HBV Genomes Using Low Doses of Adenovirus Vectors Leads to Persistent Infection in Immune Competent Mice
Keywords: Mouse Model; Liver Disease; Virology; Immunity; AdHBV; adenoviral HBV genome transfer; ALT; alanine aminotransferase; anti-HBs; antibodies to hepatitis B surface antigen; CTL; cytotoxic T lymphocyte; HBc; hepatitis B core; HBcAg; hepatitis B core antigen;
The inhibition of the T-cell immunoglobulin and mucin domain 3 (Tim3) pathway enhances the efficacy of tumor vaccine
Keywords: Tim3; Tim3-inhibition; Tregs; Tumor vaccine; Immunotherapy